A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

Completed · Phase 3

Conditions studied: Pulmonary Arterial Hypertension

In brief

This is a prospective, multicenter, open-label, randomized, controlled, parallel Phase 3 study with an open-label single-arm extension period to evaluate pharmacokinetics (PK), safety and efficacy of macitentan in children with pulmonary arterial hypertension (PAH).

Key facts

Study ID
NCT02932410
Run by
Actelion
People needed
165
Starts
2017-10-24
Expected to finish
2025-11-27
Last updated by the study team
2026-03-13

Who can join

Age: 0 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.